Yonsung

Yonsung

Hamburg, Germany· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Yonsung GmbH is a Hamburg-based, privately-held company that functions as the EU arm of the Korean API manufacturer Yonsung Fine Chemicals Co., Ltd. Founded in 2000, the parent company is a USFDA, EU, and Japan-approved manufacturer of high-quality APIs, notably in the Prostaglandin space. The German subsidiary, led by Managing Director René Schmid, is responsible for EU-related projects, customer support, and market access, positioning itself as a quality-focused service and distribution partner for European pharmaceutical firms.

Medical DevicesDrug Delivery

Technology Platform

Acts as EU commercial/regulatory arm for parent company's API synthesis platform, specializing in complex Prostaglandin manufacturing under ICH Q7, USFDA, EU, and Japan approvals.

Opportunities

The growing, high-value niche market for complex APIs like Prostaglandins in the regulated EU pharmaceutical space presents a significant opportunity.
By providing localized regulatory support and service as the EU face of a specialized Korean manufacturer, the company can capture value from customers seeking reliable, high-quality supply chains.

Risk Factors

Key risks include extreme supply chain concentration on a single Korean manufacturing source, regulatory compliance failures in the complex EU environment, and competitive pressure in the API market.
The company's strategic dependency on its parent group's decisions also poses a risk.

Competitive Landscape

Yonsung GmbH competes with other API distributors and direct manufacturers, both in Europe and Asia, supplying the EU market. Its differentiation is based on its specialized focus on Prostaglandins, the quality credentials of its parent manufacturer, and its localized EU presence providing regulatory and customer service support.